Company: SHPH
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001493152-25-002253
Chunk: 246

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-15
Form: S-1
Chunk 246
---
 of the University of California and Dr. Robert Favell (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed December 19, 2024).                     |
| 14.1   |     | Code                                                                                                                                                                                                                                                                                                     
 of Business Conduct and Ethics (incorporated by reference to Exhibit 10.3 to the Registration Statement on Form S-1 (File No. 333-265429)                                                                                                                                                                
 filed on June 3, 2022).                                                                                                                                                                                                                                                                                  |
| 21     |     | List                                                                                                                                                                                                                                                                                                     
 of Subsidiaries (incorporated by reference to Exhibit 21 to the Annual Report on Form 10-K filed on March 21, 2024).                                                                                                                                                                                     |
| 23.1*  |     | Consent of Forvis Mazars, LLP*                                                                                                                                                                                                                                                                           |
| 23.2   |     | Consent of Dorsey & Whitney LLP (included in Exhibit 5.1)                                                                                                                                                                                                                                                |
| 24*    |     | Power of Attorney (included in the signature page to this registration statement).                                                                                                                                                                                                                       |
| 107    |     | Filing Fee Table                                                                                                                                                                                                                                                                                         |

*To be filed

◊Previously filed

+Certain portions of this exhibit have been redacted in accordance with Item 601(b)(10)(iv) because such information (i) is deemed not material and (ii) is of the type of information that the Company normally treats as private or confidential.

| II-5 |

| ITEM 
 17.  | UNDERTAKINGS |

The undersigned registrant hereby undertakes:

(a) (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high and of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424